ChromaDex
CDXC
#7065
Rank
A$0.92 B
Marketcap
A$11.89
Share price
-0.88%
Change (1 day)
82.40%
Change (1 year)

Earnings for ChromaDex (CDXC)

Earnings in 2024 (TTM): A$13.97 Million

According to ChromaDex's latest financial reports the company's current earnings are A$99.59 Million. , an increase over its 2023 earnings that were of -A$7.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ChromaDex from 2007 to 2024

Annual earnings

Year Earnings Change
2024 A$13.37 M-279.32%
2023 -A$7.47 Million-70.15%
2022 -A$24.99 Million-39.03%
2021 -A$40.99 Million36.15%
2020 -A$30.11 Million-38.02%
2019 -A$48.57 Million-3.51%
2018 -A$50.34 Million101.55%
2017 -A$24.98 Million470.57%
2016 -A$4.38 Million4.72%
2015 -A$4.18 Million-48.66%
2014 -A$8.15 Million21.92%
2013 -A$6.68 Million-62.08%
2012 -A$17.61 Million48.18%
2011 -A$11.89 Million289.87%
2010 -A$3.05 Million125.95%
2009 -A$1.35 Million-54.35%
2008 -A$2.96 Million8290.97%
2007 -A$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sangamo Therapeutics
SGMO
-A$0.17 Billion-1,345.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.61 B 11,936.59%๐Ÿ‡บ๐Ÿ‡ธ USA